In accordance with the observation that the CD8+ T-cell signal peaks 14 days after COVID-19 symptom onset [26], our method seemed more performant on samples taken later after symptom onset (days 14–21 compared to days 7–14), although this effect was not statistically significant. This evidence concerns the gene CD8A and COVID-19.